Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$694K Buy
4,776
+23
+0.5% +$3.18K 0.32% 75
2026
Q2
$611K Sell
4,753
-85
-2% -$9.9K 0.27% 93
2026
Q1
$582K Sell
4,838
-9
-0.2% -$1.04K 0.28% 84
2025
Q4
$510K Sell
4,847
-176
-4% -$16.5K 0.25% 97
2025
Q3
$422K Sell
5,023
-225
-4% -$18.5K 0.21% 104
2025
Q2
$415K Sell
5,248
-304
-5% -$24.2K 0.21% 96
2025
Q1
$498K Buy
5,552
+472
+9% +$44.1K 0.28% 77
2024
Q4
$505K Sell
5,080
-418
-8% -$43.1K 0.5% 57
2024
Q3
$624K Buy
+5,498
New +$653K 0.62% 51

Other funds holding MRK

CWC Advisors's MRK Position: Q3 2026 in Review

CWC Advisors increased its Merck (MRK) stake by 0.48% in Q3 2026, buying an estimated $3.18K and bringing the position to 4,776 shares worth $694K. The position accounts for 0.32% of the portfolio, ranked #75.

CWC Advisors first reported a position in MRK in Q3 2024 and has held it in 9 quarters since. 1,510 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • CWC Advisors held 4,776 shares of Merck worth $694K as of Q3 2026.
  • CWC Advisors bought 23 Merck shares in Q3 2026, an estimated $3.18K.
  • Merck made up 0.32% of CWC Advisors's portfolio in Q3 2026, its #75 holding.
  • CWC Advisors first reported a position in Merck in Q3 2024 and has held it in 9 quarters since.
  • 1,510 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on CWC Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.